Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The control of the vitamin content in the blood after 3 months of treatment showed an increase in the serum concentrations of pyridoxine [from 8.1 (5.8 to 11.8) µg/L to 13.9 (9.2 to 16.3) µg/L; p < 0.001], folic acid [from 3.7 (3.0 to 4.7) µg/L to 6.6 (5.7 to 8.2) µg/L; p < 0.001], cyanocobalamin [from 293.3 (234.8 to 323.2) ng/L to 411.1 (358.5 to 511.4) ng/L; p < 0.001], and 25(OH)D [from 17.8 (13.9 to 23.6) ng/ml to 33.5 (29.4 to 38.2) ng/ml; p < 0.001].

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The effects of vitamin B and D supplementations on autonomic functions and quality of life in children after vasovagal syncope

Study design awaiting verification · Frontiers in Pediatrics · 2025

Original publication title

The effects of vitamin B and D supplementations on autonomic functions and quality of life in children after vasovagal syncope

Tetiana Kovalchuk; Oksana Boyarchuk; Nataliya Balatska

© 2025 Kovalchuk, Boyarchuk and Balatska.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The use of vitamin B6, B9, B12, and D3 supplements in therapeutic and preventive doses over 3 months in patients with a history of VVS is associated with a reduction in symptoms and syncope frequency, a decrease in serum homocysteine levels, a reduction in autonomic dysregulation, and an improvement in the QOL for children and their families.

An extract from the source publication. Read it in context.

At a glance

Abstract: What methods does the paper describe?

The study involved 68 adolescents with VVS who consistently took vitamin B and D supplements and returned for the examination after 3 months. The effectiveness of the therapy was assessed using the CSSS (Calgary Syncope Seizure Score) and MCSSS (Modified Calgary Syncope Seizure Score), serum vitamin profiles (measured using the ELISA method), heart rate variability, blood pressure variability, and the PedsQL™ (Pediatric Quality of Life Inventory™) 4.0 Generic Core Scales and PedsQL™ 2.0 Family Impact Module surveys.

Source: Materials and methods

Abstract: Aim of the study

The aim of the study was to assess the effectiveness of vitamin B6, B9, B12, and D3 supplements in reducing symptoms and the frequency of syncope, improving autonomic nervous system functions, and enhancing quality of life (QOL) in children following an episode of vasovagal syncope (VVS).

Source: Aim of the study

Abstract: Results

The study demonstrated that 3 months of vitamin supplementation were associated with a significant reduction in the frequency of symptoms and syncope episodes (p < 0.05). A marked decrease in serum homocysteine levels was observed, from 13.8 (9.9 to 17.9) µmol/L to 8.5 (7.6 to 10.8) µmol/L (p < 0.001). Vitamin supplementation also resulted in improved heart rate variability, evidenced by a significant increase in the SDANN index (p = 0.03) and reductions in TP (p = 0.002), LF (p = 0.004), and LF/HF (p = 0.01), indicating a decrease in sympathotonic influences on the cardiovascular system.

Additionally, improved cardiac autonomic function in children with VVS during therapy was reflected by a higher prevalence of dipper profiles for systolic (p = 0.008) and diastolic (p < 0.001) blood pressure. During the 3-month therapy, the QOL in children showed improvements in physical, emotional, and school functioning (p < 0.05). In parents of children with a history of VVS, there were enhancements in physical, emotional, social, and cognitive functioning, as well as in communication and a reduction in worry levels.

Among family members, daily activities and family relationships also improved (p < 0.05).

Source: Results

Abstract: Conclusion

The use of vitamin B6, B9, B12, and D3 supplements in therapeutic and preventive doses over 3 months in patients with a history of VVS is associated with a reduction in symptoms and syncope frequency, a decrease in serum homocysteine levels, a reduction in autonomic dysregulation, and an improvement in the QOL for children and their families.

Source: Conclusion
Authors’ abstract

Aim of the study

The aim of the study was to assess the effectiveness of vitamin B6, B9, B12, and D3 supplements in reducing symptoms and the frequency of syncope, improving autonomic nervous system functions, and enhancing quality of life (QOL) in children following an episode of vasovagal syncope (VVS).

Materials and methods

The study involved 68 adolescents with VVS who consistently took vitamin B and D supplements and returned for the examination after 3 months. The effectiveness of the therapy was assessed using the CSSS (Calgary Syncope Seizure Score) and MCSSS (Modified Calgary Syncope Seizure Score), serum vitamin profiles (measured using the ELISA method), heart rate variability, blood pressure variability, and the PedsQL™ (Pediatric Quality of Life Inventory™) 4.0 Generic Core Scales and PedsQL™ 2.0 Family Impact Module surveys.

Results

The study demonstrated that 3 months of vitamin supplementation were associated with a significant reduction in the frequency of symptoms and syncope episodes (p < 0.05). A marked decrease in serum homocysteine levels was observed, from 13.8 (9.9 to 17.9) µmol/L to 8.5 (7.6 to 10.8) µmol/L (p < 0.001). Vitamin supplementation also resulted in improved heart rate variability, evidenced by a significant increase in the SDANN index (p = 0.03) and reductions in TP (p = 0.002), LF (p = 0.004), and LF/HF (p = 0.01), indicating a decrease in sympathotonic influences on the cardiovascular system.

Additionally, improved cardiac autonomic function in children with VVS during therapy was reflected by a higher prevalence of dipper profiles for systolic (p = 0.008) and diastolic (p < 0.001) blood pressure. During the 3-month therapy, the QOL in children showed improvements in physical, emotional, and school functioning (p < 0.05). In parents of children with a history of VVS, there were enhancements in physical, emotional, social, and cognitive functioning, as well as in communication and a reduction in worry levels.

Among family members, daily activities and family relationships also improved (p < 0.05).

Conclusion

The use of vitamin B6, B9, B12, and D3 supplements in therapeutic and preventive doses over 3 months in patients with a history of VVS is associated with a reduction in symptoms and syncope frequency, a decrease in serum homocysteine levels, a reduction in autonomic dysregulation, and an improvement in the QOL for children and their families.

Publication and source details

Original title: The effects of vitamin B and D supplementations on autonomic functions and quality of life in children after vasovagal syncope

Tetiana Kovalchuk; Oksana Boyarchuk; Nataliya Balatska

Frontiers in Pediatrics · 2025

Edited by: Angharad Vernon-Roberts, University of Otago, New Zealand

Reviewed by: Juan Luis Perez Navero, Hospital Reina Sofía de Córdoba, Spain

Runmei Zou, Central South University, China

* Correspondence: Tetiana Kovalchuk tetianakovalchuk@gmail.com
© 2025 Kovalchuk, Boyarchuk and Balatska.2025Kovalchuk, Boyarchuk and Balatskahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:36:23.759942+00:00

DOI: 10.3389/fped.2025.1553428 · PMC11934251